Keywords: SA, FDA, Promotion, Eli Lilly, Amylin, Cephalon, Bayer, Cymbalta, Byetta, Mirena, Treanda

US FDA warns four drugmakers on inaccurate promotion

Article | 13 January 2010

Print This

The US Food and Drug Administration yesterday sent warning letters to domestic drugmakers Eli Lilly, Amylin and Cephalon, as well ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in